Chemaphor and Elanco End Relationship
US - Chemaphor announced today that they have agreed to end their relationship with Elanco, the animal health division of Eli Lilly and Company, and with this to terminate their contractual arrangement immediately.
11 August 2009
2 minute read
All rights to Chemaphor's technology revert to Chemaphor without restriction, enabling Chemaphor to immediately engage in partnership discussions with other interested global animal health care companies in the poultry, swine, cattle and aquaculture markets.
Chemaphor is a health and wellness company that has multiple product opportunities within multiple markets. The company says that it will continue to pursue development and commercialization strategies for each of these markets.
